June 18, 2026
TAM Center Officially Opens its Doors in Mexico: A New Global Hub for Cancer Diagnosis, Regenerative Medicine, and Translational Science
TAM Global is proud to announce the official opening of the TAM Center in Tijuana, Mexico, positioning it as an advanced translational medicine and regenerative healthcare hub. The release highlighted the facility’s genomics capabilities, stem cell manufacturing infrastructure, AI integration, diagnostics partnership with Roche, imaging technologies, and multidisciplinary scientific team focused on cancer, chronic disease, and personalized medicine.
Read Release
June 23, 2026
Dr. Francesco Marincola Named Chief Scientific Officer of TAM Global
TAM Global announced the appointment of internationally recognized tumor immunologist Dr. Francesco Marincola as Chief Scientific Officer. The release emphasized his extensive NIH and translational medicine background and described his role overseeing TAM’s scientific strategy across diagnostics, genomics, AI, cellular therapy, and precision medicine initiatives.
Read Release
January 8, 2026
TAM Global Study Brings Clarity and Scientific Rigor to the Mesenchymal Stem Cell Landscape
TAM Global publication of a peer-reviewed study in the Journal of Translational Medicine establishing an evidence-based framework for evaluating mesenchymal stem cell (MSC) therapies. The paper aimed to distinguish scientifically validated MSC therapies from commercially marketed stem cell claims lacking robust evidence.
Read Release
January 29, 2026
TAM Global Study Challenges Stem Cell Claims for Wharton’s Jelly Commercial Products
TAM Global announced findings from a peer-reviewed study concluding that commercially available Wharton’s jelly products do not contain clinically meaningful quantities of viable stem cells. The release argued for clearer distinctions between structural biologic products and true stem cell therapies and emphasized transparency in regenerative medicine marketing.
Read Release
March 23, 2026
Translational Insights Launches, Introducing a New Era in Translational Medicine
TAM Global announced the launch of Translational Insights, a new scientific journal led by TAM’s Chief Scientific Officer, Dr. Marincola, focused on rethinking the traditional “bench-to-bedside” model. The journal promotes a human-centered, bidirectional translational medicine framework emphasizing earlier use of human biological data and real-world clinical insights.
Read Release
April 2, 2026
New Paper in Translational Insights Presents a Unifying Theory for How the Immune System Recognizes Cancer
TAM Global announced the publication of a paper proposing a new theory of cancer immunogenicity involving viral mimicry and “cancer dark matter.” The release framed the work as a potential advancement in understanding immune recognition of cancer and future immunotherapy development.
Read Release
For TAM media inquiries contact press@thetamcenter.com